BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23593632)

  • 1. The soft tissue wall technique for the regenerative treatment of non-contained infrabony defects: a case series.
    Rasperini G; Acunzo R; Barnett A; Pagni G
    Int J Periodontics Restorative Dent; 2013; 33(3):e79-87. PubMed ID: 23593632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects.
    Ogihara S; Wang HL
    J Periodontol; 2010 Dec; 81(12):1734-42. PubMed ID: 20629545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic parameters for prognosis of periodontal healing of infrabony defects: two different definitions of defect depth.
    Eickholz P; Hörr T; Klein F; Hassfeld S; Kim TS
    J Periodontol; 2004 Mar; 75(3):399-407. PubMed ID: 15088878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity.
    Cortellini P; Tonetti MS
    J Clin Periodontol; 2007 Jan; 34(1):87-93. PubMed ID: 17243998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
    Cortellini P; Tonetti MS
    J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gingival recessions by combined periodontal regenerative technique, guided tissue regeneration, and subpedicle connective tissue graft. A comparative clinical study.
    Paolantonio M
    J Periodontol; 2002 Jan; 73(1):53-62. PubMed ID: 11846201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft-tissue re-growth following fibre retention osseous resective surgery or osseous resective surgery: a multilevel analysis.
    Cairo F; Carnevale G; Buti J; Nieri M; Mervelt J; Tonelli P; Pagavino G; Tonetti M
    J Clin Periodontol; 2015 Apr; 42(4):373-9. PubMed ID: 25692329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
    Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
    J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.